Seroquel

(redirected from quetiapine fumarate)
Also found in: Medical.

Se·ro·quel

 (sĕr′ə-kwĕl′)
A trademark for the fumarate salt of the drug quetiapine.
References in periodicals archive ?
com adds "Global and China Olanzapine Industry 2015 Research Report" , "2015 Global Quetiapine Fumarate Industry Report" and "Global Montelukast Sodium Industry 2015 - 2020" Research Report to its store.
Subsequently, agomelatine treatment was discontinued and it was replaced with quetiapine fumarate 25 mg/day (taken at bedtime).
The FDA's Psychopharmacologic Drugs Advisory Committee voted that quetiapine fumarate (Seroquel XR) is safe as an adjunctive therapy for major depressive disorder and generalized anxiety disorder, but only in certain instances as a first-line therapy for MDD and not as a standalone treatment for GAD.
Quetiapine fumarate is safe as an adjunctive therapy for major depressive disorder and generalized anxiety disorder, according to a Food and Drug Administration panel.
State Hospital, did something he almost never has to do: In consultation with attending physicians, he switched 17 patients from one drug--the antipsychotic quetiapine fumarate (Seroquel)--to other medications.
Long-term effects of quetiapine fumarate in parkinsonism complicated by psychosis.
announces the approval of Quetiapine Fumarate Tablets.
Quetiapine fumarate is an atypical antipsychotic medication FDA approved and used for the treatment of affective disorders and schizophrenia, and is used off-label in the management of several other psychiatric disorders.
operating subsidiary has entered into an exclusive acquisition and license agreement with Handa Pharmaceuticals, LLC to acquire Handa's Abbreviated New Drug Application (ANDA) for quetiapine fumarate extended-release tablets, the generic version of AstraZeneca's Seroquel XR[sup.
Reddy's Laboratories (NYSE: RDY) announced today that it has launched Quetiapine fumarate tablets (25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg), a bioequivalent generic version of SEROQUEL([R])tablets in the US market on March 27, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr.
Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quetiapine Fumarate Tablets, 25 mg.
Food and Drug Administration ("FDA") had granted tentative approval of the Company's Abbreviated New Drug Application ("ANDA") for Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300 mg, and 400 mg, a generic version of AstraZeneca's SEROQUEL XR.